Posts for 1/2019


HSD17B13 (Hydroxysteroid 17-Beta Dehydrogenase 13)

Jan 23, 2019

HSD17B13, a member of a large family of 17β-hydroxysteroid dehydrogenases, gained a sudden fame recently. A genetic study in 2018 discovered that a genetic variant is associated with a reduced risk for chronicle liver diseases, including NAFLD (non-alcoholic fatty liver disease) and NASH (non-alcoholic steatohepatitis). More studies indicate the progress of NASH to HCC can also be reduced by the presence of the variant. Clin...

Read more...

Archives: